The efficacy of a single dose of infliximab in the treatment of Behçet's disease uveitis

Clin Exp Rheumatol. 2005 May-Jun;23(3):427.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Behcet Syndrome / complications
  • Behcet Syndrome / drug therapy*
  • Drug Therapy, Combination
  • Humans
  • Infliximab
  • Male
  • Prednisone / therapeutic use
  • Treatment Outcome
  • Uveitis, Anterior / drug therapy*
  • Uveitis, Anterior / etiology
  • Uveitis, Posterior / drug therapy*
  • Uveitis, Posterior / etiology
  • Vitreous Body / drug effects
  • Vitreous Body / physiopathology

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab
  • Prednisone